Bayer Is Proposing a $7.25 Billion Deal to Settle Roundup Cancer Cases — Including Future Ones

What's happening: Bayer, the company that makes Roundup weed killer, is proposing a new $7.25 billion settlement to resolve cancer cases tied to its product. What makes this deal different from anything Bayer has done before is the scope — it would cover not just people who already filed cases, but anyone who develops non-Hodgkin lymphoma linked to Roundup use over the next 21 years.

Quick Background on Roundup

Roundup is one of the most widely used weed killers in the world. Its active ingredient is a chemical called glyphosate. Bayer acquired Roundup when it bought Monsanto in 2018 — and it also inherited thousands of pending lawsuits from people who say they developed non-Hodgkin lymphoma after years of exposure to the product.

Non-Hodgkin lymphoma is a type of blood cancer. Many of the people who filed cases are farmers, landscapers, groundskeepers, and homeowners who used Roundup regularly for years without knowing it might be dangerous. Since 2018, Bayer has paid out more than $11 billion to resolve previous Roundup cases. But new lawsuits kept coming — and Bayer wants to end that.

For more background on the history of these cases, see our full page on the Roundup settlement.

What's Different About This New Proposal

All of Bayer's previous Roundup settlements covered people who already had cases in the pipeline. This new proposal is different in an important way: it would also lock in a resolution for future claimants — people who haven't gotten sick yet but might over the next two decades.

Under the proposal, this single $7.25 billion fund would cover:

• People who have already filed Roundup cases
• People who have been diagnosed with non-Hodgkin lymphoma but haven't filed yet
• People who develop non-Hodgkin lymphoma within the next 21 years and can show a connection to Roundup use

Why Bayer Wants This Deal

Bayer has been dealing with Roundup lawsuits for nearly a decade. Individual cases kept going to trial, juries kept awarding large verdicts against the company, and new plaintiffs kept filing. From Bayer's perspective, this settlement is about certainty — paying a known amount now rather than facing an unknown number of trials over the next two decades.

Including future claimants is the key to that strategy. If someone who gets sick in 2035 from Roundup exposure could still file a brand-new lawsuit, Bayer's legal problems never fully go away. A settlement that covers future cases would, in theory, end the Roundup chapter for the company permanently.

The Concern With Future-Claimant Settlements

Not everyone thinks this kind of deal is a good outcome for injured people. Some attorneys who represent Roundup plaintiffs have raised concerns that a future-claimant settlement could short-change people who haven't gotten sick yet — because those people are being locked into a deal before they even know the full extent of their illness or what their individual situation is worth.

A person who develops cancer in 2031 would get whatever this settlement provides, rather than being able to negotiate based on what happened to them specifically. Critics argue it's difficult to fairly compensate someone for a harm that hasn't fully played out yet.

What You Should Do If This Affects You

If any of the following applies to you, it's important to speak with a lawyer before June 4, 2026:

• You or a family member used Roundup regularly — for farming, landscaping, lawn care, or any other purpose
• You or a family member has been diagnosed with non-Hodgkin lymphoma
• You already have an active Roundup case with a law firm

The opt-out deadline means that if you don't actively choose to stay out of this settlement, you could be included in it and give up your right to pursue your own individual case. Whether that's the right call depends entirely on your specific situation. A lawyer can help you understand whether opting out makes sense for you — most Roundup attorneys offer a free review.

This settlement is still proposed — it has not been finalized or approved by a court. But the opt-out process requires action on your part before the deadline regardless.